医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
4期
64-65
,共2页
反流性%胃炎%泮托拉唑%莫沙必利%铝碳酸镁%疗效
反流性%胃炎%泮託拉唑%莫沙必利%鋁碳痠鎂%療效
반류성%위염%반탁랍서%막사필리%려탄산미%료효
Reflux%Gastritis%Panxi tora thiazole%Moser will benefit%Aluminum magnesium carbonate%The curative effect
目的:观察泮托拉唑、莫沙必利和铝碳酸镁片三联疗法治疗成年人胆汁反流性胃炎的临床效果。方法:将2012年6月—2014年6月在我院内科就诊的胆汁反流性胃炎患者随机分为两组,观察组联合应用泮托拉唑+莫沙比利+铝碳酸镁片,对照组口服莫沙比利+铝碳酸镁片,对比分析两组患者在治疗4w后的效果。结果:共89例反流性胃炎患者入组,治疗组46例、对照组43例,总有效率分别为93.5%(43/46)和65.1%(28/43),组间差异有统计学意义(P<0.05)。结论:泮托拉唑三联疗法治疗胆汁反流性胃炎可以显著改善胃黏膜充血、水肿、糜烂等病变,效果较好。
目的:觀察泮託拉唑、莫沙必利和鋁碳痠鎂片三聯療法治療成年人膽汁反流性胃炎的臨床效果。方法:將2012年6月—2014年6月在我院內科就診的膽汁反流性胃炎患者隨機分為兩組,觀察組聯閤應用泮託拉唑+莫沙比利+鋁碳痠鎂片,對照組口服莫沙比利+鋁碳痠鎂片,對比分析兩組患者在治療4w後的效果。結果:共89例反流性胃炎患者入組,治療組46例、對照組43例,總有效率分彆為93.5%(43/46)和65.1%(28/43),組間差異有統計學意義(P<0.05)。結論:泮託拉唑三聯療法治療膽汁反流性胃炎可以顯著改善胃黏膜充血、水腫、糜爛等病變,效果較好。
목적:관찰반탁랍서、막사필리화려탄산미편삼련요법치료성년인담즙반류성위염적림상효과。방법:장2012년6월—2014년6월재아원내과취진적담즙반류성위염환자수궤분위량조,관찰조연합응용반탁랍서+막사비리+려탄산미편,대조조구복막사비리+려탄산미편,대비분석량조환자재치료4w후적효과。결과:공89례반류성위염환자입조,치료조46례、대조조43례,총유효솔분별위93.5%(43/46)화65.1%(28/43),조간차이유통계학의의(P<0.05)。결론:반탁랍서삼련요법치료담즙반류성위염가이현저개선위점막충혈、수종、미란등병변,효과교호。
ObjectiveObserve the panxi tora azole, moser and aluminum magnesium carbonate triple therapy for treatment of bile reflux gastritis, adults.MethodsWill from June 2012 to June 2012 in our medical clinic of bile reflux gastritis patients were randomly divided into 2 groups, the observation group of combined use of panxi tora azole + mo + aluminum magnesium carbonate sand Billy, the control group oral moser Billy + aluminum magnesium carbonate, comparison and analysis the effect of 2 groups of patients after treatment of 4 w. ResultsA total of 89 cases of reflux gastritis patients into groups, the treatment group 43 cases, 46 cases, control group total effective rate was 93.5% (43/46) and 65.1% (28/43), the difference between groups was statistically significant (P<0.05).Conclusions Panxi tora azole triple therapy in the treatment of bile reflux gastritis can significantly improve gastric mucosa hyperemia and edema, erosion lesions, the effect is better.